<?xml version="1.0" encoding="UTF-8"?>
<p>Figures 
 <xref ref-type="fig" rid="fig1">1(c)</xref> and 
 <xref ref-type="fig" rid="fig1">1(d)</xref> show the changes in reduced glutathione level (
 <xref ref-type="fig" rid="fig1">Figure 1(c)</xref>) and catalase activity (
 <xref ref-type="fig" rid="fig1">Figure 1(d)</xref>) levels of animals treated daily and concomitantly with L-NAME and either the aqueous extract of 
 <italic>A. digitata</italic> or captopril for 3 weeks. Catalase activity was decreased in the aorta and in the heart of hypertensive control animals compared to the normotensive control group (
 <xref ref-type="fig" rid="fig1">Figure 1(c)</xref>). 
 <italic>A. digitata</italic> (100 and 200â€‰mg/kg) treatment increased significantly the catalase activity in the aorta (68.68%, 
 <italic>p</italic> &lt; 0.01, and 75.68%, 
 <italic>p</italic> &lt; 0.001, respectively) and in the kidney (92.25%, 
 <italic>p</italic> &lt; 0.001, and 57.30%, 
 <italic>p</italic> &lt; 0.01) (
 <xref ref-type="fig" rid="fig1">Figure 1(c)</xref>). Treatment with captopril significantly increased catalase activity in the heart (86.64%, 
 <italic>p</italic> &lt; 0.001) and in the kidney (88.36%, 
 <italic>p</italic> &lt; 0.001) compared to the hypertensive control group (
 <xref ref-type="fig" rid="fig1">Figure 1(c)</xref>).
</p>
